Deal offers 150,915 common shares at $13.2525 each to Zenyaku Kogyo
By Devika Patel
Knoxville, Tenn., Aug. 17 – Anthera Pharmaceuticals, Inc. negotiated a $2 million registered direct offering of stock Zenyaku Kogyo Co., Ltd. on Aug. 14, according to a prospectus supplement and 8-K filed Monday with the Securities and Exchange Commission.
The company will sell 150,915 common shares at $13.2525 apiece. The price per share is a 34.95% premium to the Aug. 13 closing share price of $9.82.
Settlement was expected Monday.
Proceeds will be used for clinical research and development.
Anthera, based in Hayward, Calif., is a biopharmaceutical company.
| Issuer: | Anthera Pharmaceuticals, Inc.
|
| Issue: | Common shares
|
| Amount: | $2 million
|
| Shares: | 150,915
|
| Price: | $13.2525
|
| Warrants: | No
|
| Investor: | Zenyaku Kogyo Co., Ltd.
|
| Pricing date: | Aug. 14
|
| Settlement date: | Aug. 17
|
| Stock symbol: | Nasdaq: ANTH
|
| Stock price: | $9.82 at close Aug. 13
|
| Market capitalization: | $399.81 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
